Skip to main content
. Author manuscript; available in PMC: 2009 Jul 13.
Published in final edited form as: Exp Neurol. 2008 Mar 19;211(2):574–584. doi: 10.1016/j.expneurol.2008.03.004

Figure 6. Increased ChAT positive cell area but no change in cell number following CERE-110 delivery to the NBM of the young rat.

Figure 6

(A) NBM ChAT-positive cell number at 3 months, 6 months, 9 months, and 12 months following delivery of formulation buffer control and optimal and high dose CERE-110 to the NBM. (B) NBM ChAT-positive cross-sectional cell area at 3 months, 6 months, 9 months and 12 months following FB control and optimal and high dose CERE-110 delivery to the. Error bars represent standard error of the mean (SEM). *Significantly different compared to FB control (p < 0.05).